CMY-42, a novel plasmid-mediated CMY-2 variant AmpC beta-lactamase

Microbial Drug Resistance

Volumn 17, Issue 2, 2011, Pages 165-169

  Hentschke, Moritz ^a   Kotsakis, Stathis D ^b   Wolters, Manuel ^a   Heisig, Peter ^c   Miriagou, Vivi ^b   Aepfelbacher, Martin ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAMASE AMPC; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEPHALOSPORIN; CMY 42; OXACILLIN; PENICILLIN G; SODIUM AZIDE; TAZOBACTAM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PLASMIDS; SERINE; SURGICAL WOUND INFECTION; VALINE;

ESCHERICHIA COLI;

EID: 79957628619     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2010.0137     Document Type: Article

References (12)

1. Antunes, P., T.M. Coque, and L. Peixe. 2010. Emergence of an IncIgamma plasmid encoding CMY-2 ss-lactamase associated with the international ST19 OXA-30-producing sslactamase Salmonella Typhimurium multidrug-resistant clone. J. Antimicrob. Chemother. 65:2097-2100.
2. Dallenne, C., A. Da Costa, D. Decre, C. Favier, and G. Arlet. 2010. Development of a set of multiplex PCR assays for the detection of genes encoding important betalactamases in Enterobacteriaceae. J. Antimicrob. Chemother. 65:490-495.
3. Dubois, V., C. Arpin, C. Quentin, J. Texier-Maugein, L. Poirel, and P. Nordmann. 2003. Decreased susceptibility to cefepime in a clinical strain of Escherichia coli related to plasmid-and integron-encoded OXA-30 beta-lactamase. Antimicrob. Agents Chemother. 47:2380-2381. (Pubitemid 36753609)
4. Jacoby, G.A. 2009. AmpC beta-lactamases. Clin. Microbiol. Rev. 22:161-182
5. Kotsakis, S.D., C.C. Papagiannitsis, E. Tzelepi, L.S. Tzouvelekis, and V. Miriagou. 2009. Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase. Antimicrob. Agents Chemother. 53:3520-3523.
6. Mammeri, H., F. Eb, A. Berkani, and P. Nordmann. 2008. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital. J. Antimicrob. Chemother. 61:498-503. (Pubitemid 351321120)
7. Oellerich, M.F., C.A. Jacobi, S. Freund, K. Niedung, A. Bach, J. Heesemann, and K. Trulzsch. 2007. Yersinia enterocolitica infection of mice reveals clonal invasion and abscess formation. Infect. Immun. 75:3802-3811. (Pubitemid 47206277)
8. Perez-Perez, F.J., and N.D. Hanson. 2002. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162. (Pubitemid 34596400)
9. Philippon, A., G. Arlet, and G.A. Jacoby. 2002. Plasmiddetermined AmpC-type beta-lactamases. Antimicrob. Agents Chemother. 46:1-11.
10. Pope, C.E., P.E. Carter, and H.M. Heffernan. 2009. CMY-29 and CMY-30, two novel plasmid-mediated AmpC betalactamases. Antimicrob. Agents Chemother. 53:3178.
11. Powers, R.A., E. Caselli, P.J. Focia, F. Prati, and B.K. Shoichet. 2001. Structures of ceftazidime and its transitionstate analogue in complex with AmpC beta-lactamase: implications for resistance mutations and inhibitor design. Biochemistry 40:9207-9214. (Pubitemid 32730042)
12. Zioga, A., J.M. Whichard, S.D. Kotsakis, L.S. Tzouvelekis, E. Tzelepi, and V. Miriagou. 2009. CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids. Antimicrob. Agents Chemother. 53:1256-1259.